Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Non-Current Debt: 2016

  • Niagen Bioscience's Non-Current Debt was N/A to $3.3 million in Q1 2016 from the same period last year, while for Jan 2016 it was $3.3 million, marking a year-over-year change of. This contributed to the annual value of $3.3 million for FY2016, which is N/A change from last year.
  • Latest data reveals that Niagen Bioscience reported Non-Current Debt of $3.3 million as of Q1 2016.
  • Over the past 5 years, Niagen Bioscience's Non-Current Debt peaked at $3.3 million during Q1 2016, and registered a low of $3.3 million during Q1 2016.
  • For the 1-year period, Niagen Bioscience's Non-Current Debt averaged around $3.3 million, with its median value being $3.3 million (2016).